From Dr. Jacob Glanville twitter account - RNA vaccine
From Dr. Jacob Glanville twitter account - RNA vaccine ingredients. These vaccines have RNA wrapped up inside tiny droplets of oil and cholesterol. The lipids are similar to your cells - they have mild chemical charge on one side that orients the RNA (short-lived genetic message encoding the coronavirus spike protein) inside them (biological systems do this all the time). There is also polyethalene glycol - this is a common compounds used in medicines to make them more water soluble, it’s also used as a constipation medicine when given at high doses and in a bunch of other applications. No, the vaccine doesn’t have any formalin or stem cells or “green monkey cells” (I actually don’t know what that is - got it in a question this morning), or carcinogens in it. It’s droplets of oil that protect the RNA until your cells take it up & process the RNA instructions The RNA cannot incorporate into your genome so it’s not genome editing - it degrades after a few days like all other RNA. That’s why you need a second booster shot four weeks later.
2
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...
Continue Reading
Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...
Continue Reading
Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...
Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...
Continue Reading
Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...
Continue Reading
